Compound ID | 1122
Synonym(s): SQ 30213
Class: Beta-lactam (monobactam)
Spectrum of activity: | Gram-positive & Gram-negative |
Details of activity: | Good activty against gram negative bacteria with the exception of Pseudomonas. |
Description: | Chin, N. X., and H. C. Neu. "Tigemonam, an oral monobactam." Antimicrobial agents and chemotherapy 32.1 (1988): 84-91. |
Institute where first reported: | Bristol Myers Squibb |
Year first mentioned: | 1985 |
Highest developmental phase: | Preclinical |
Development status: | Inactive |
Reason Dropped: | Discontinued in 1994 due to… |
Chemical structure(s): | |
Canonical SMILES: | CC1(C)[C@@H](C(=O)N1OS(=O)(=O)O)NC(=O)/C(=N\OCC(=O)O)/C2=CSC(=N2)N |
Isomeric SMILES: | CC1([C@@H](C(=O)N1OS(=O)(=O)O)NC(=O)/C(=N\OCC(=O)O)/C2=CSC(=N2)N)C |
InChI: | InChI=1S/C12H15N5O9S2/c1-12(2)8(10(21)17(12)26-28(22,23)24)15-9(20)7(16-25-3-6(18)19)5-4-27-11(13)14-5/h4,8H,3H2,1-2H3,(H2,13,14)(H,15,20)(H,18,19)(H,22,23,24)/b16-7-/t8-/m1/s1 |
InChI Key: | VAMSVIZLXJOLHZ-QWFSEIHXSA-N |
Structure link: | https://pubchem.ncbi.nlm.nih.gov/compound/9576769 |
External links: | |
Guide to Pharmacology: | tigemonam |
Patent: | US20140128364A1 |